Home › Mga Karamdaman sa Labis na Pagkatulog › Alabama
Pag-aaral pangklinika para sa Mga Karamdaman sa Labis na Pagkatulog sa Alabama
7 pag-aaral para sa Mga Karamdaman sa Labis na Pagkatulog ang naghahanap ng mga kalahok sa mga site sa Alabama.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence
- Birmingham, Alabama, Birmingham
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07598708A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)
- Sleep Disorders Center of Alabama, Birmingham
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 14, 2026 · NCT07500090A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1
- Alkermes Investigational Site, Cullman
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07455383A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2
- Alkermes Investigational Site, Cullman
Nagre-recruitPhase 3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT07502443A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
- Alkermes Investigational Site, Cullman
Nagre-recruitPhase 2/3
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Ago 7, 2026 · NCT06767683Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)
- Clinical Research Site, Auburn
- Clinical Research Site, Cullman
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06568367A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
- Auburn, alabama, Auburn
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Abr 16, 2026 · NCT07096674Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.